Humacyte Inc (HUMA)
4.41
+0.01
(+0.23%)
USD |
NASDAQ |
May 03, 16:00
4.41
0.00 (0.00%)
After-Hours: 19:52
Humacyte Enterprise Value: 443.52M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 443.52M |
| May 01, 2024 | 443.52M |
| April 30, 2024 | 386.36M |
| April 29, 2024 | 406.61M |
| April 26, 2024 | 394.70M |
| April 25, 2024 | 383.98M |
| April 24, 2024 | 374.45M |
| April 23, 2024 | 387.55M |
| April 22, 2024 | 360.16M |
| April 19, 2024 | 360.16M |
| April 18, 2024 | 347.06M |
| April 17, 2024 | 291.10M |
| April 16, 2024 | 283.95M |
| April 15, 2024 | 261.32M |
| April 12, 2024 | 262.52M |
| April 11, 2024 | 279.19M |
| April 10, 2024 | 275.61M |
| April 09, 2024 | 281.57M |
| April 08, 2024 | 288.71M |
| April 05, 2024 | 281.57M |
| April 04, 2024 | 291.10M |
| April 03, 2024 | 280.38M |
| April 02, 2024 | 273.23M |
| April 01, 2024 | 278.00M |
| March 28, 2024 | 289.90M |
| Date | Value |
|---|---|
| March 27, 2024 | 288.71M |
| March 26, 2024 | 285.14M |
| March 25, 2024 | 293.47M |
| March 22, 2024 | 313.72M |
| March 21, 2024 | 348.25M |
| March 20, 2024 | 330.14M |
| March 19, 2024 | 327.80M |
| March 18, 2024 | 330.14M |
| March 15, 2024 | 298.55M |
| March 14, 2024 | 289.19M |
| March 13, 2024 | 304.40M |
| March 12, 2024 | 306.74M |
| March 11, 2024 | 283.35M |
| March 08, 2024 | 313.76M |
| March 07, 2024 | 302.06M |
| March 06, 2024 | 313.76M |
| March 05, 2024 | 326.63M |
| March 04, 2024 | 285.52M |
| March 01, 2024 | 255.45M |
| February 29, 2024 | 370.53M |
| February 28, 2024 | 375.72M |
| February 27, 2024 | 389.19M |
| February 26, 2024 | 390.23M |
| February 23, 2024 | 368.46M |
| February 22, 2024 | 365.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
65.14M
Minimum
Dec 28 2022
1.713B
Maximum
Sep 01 2021
350.52M
Average
250.91M
Median
Enterprise Value Benchmarks
| Adial Pharmaceuticals Inc | 4.431M |
| Gritstone Bio Inc | 45.67M |
| Precision BioSciences Inc | -19.29M |
| Puma Biotechnology Inc | 241.86M |
| Revance Therapeutics Inc | 568.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.11M |
| Total Expenses (Quarterly) | 26.18M |
| EPS Diluted (Quarterly) | -0.24 |
| Earnings Yield | -24.26% |